Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry.
Yusuke YoshikawaYodo TamakiTakeshi MorimotoHidenori YakuErika YamamotoYasutaka InuzukaNeiko OzasaTakeshi KitaiKazuya NagaoYukihito SatoHirokazu KondoToshihiro TamuraYoshihisa NakagawaKoichiro KuwaharaTakao KatoTakeshi KimuraPublished in: PloS one (2020)
ACE-I/ARB for patients who were hospitalized for acute HF was associated with significantly lower risk for a composite of all-cause death and HF hospitalization in HFrEF and HFmrEF, but not in HFpEF. ACE-I/ARB might be a potential treatment option in HFmrEF as in HFrEF.
Keyphrases
- acute heart failure
- ejection fraction
- aortic stenosis
- heart failure
- angiotensin converting enzyme
- left ventricular
- angiotensin ii
- liver failure
- transcatheter aortic valve replacement
- acute myocardial infarction
- respiratory failure
- mitral valve
- hypertrophic cardiomyopathy
- aortic valve
- intensive care unit
- acute coronary syndrome
- aortic dissection
- atrial fibrillation
- coronary artery disease
- climate change
- combination therapy
- left atrial
- acute respiratory distress syndrome